CASI Pharmaceuticals (CASI) Q3 2025 Earnings

29AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.86
-0.73
-0.6
-0.47

Details

Expected EPS
-0.47
Actual EPS
-0.86
Surprise EPS
-0.39
Surprise Percent
+82.98%

Description

CASI Pharmaceuticals (CASI) has reported earnings of -0.86 per share for Q3 2025.

0 Comments

Share your thoughts